Target Discovery and Validation Reviews and Protocols

In Vivo Assay of Human Angiogenesis 267
3. Folkman, J. (2003) Fundamental concepts of the angiogenic process. Curr. Mol.
Med. 3, 643–651.
4. Losordo, D. W. and Dimmeler, S. (2004) Therapeutic angiogenesis and vasculogenesis
for ischemic disease. Part II: Cell-based therapies. Circulation 109,
2692–2697.
5. Boehm, T., Folkman, J., Browder, T., and O’Reilly, M. S. (1997) Antiangiogenic
therapy of experimental cancer does not induce acquired drug resistance. Nature
390, 404–407.
6. Hurwitz, H., Fehrenbacher, L., Novotny, W., et al. (2004) Bevacizumab plus
irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl.
J. Med. 350, 2335–2342.
7. Ferrara, N., Hillan, K. J., and Novotny, W. (2005) Bevacizumab (Avastin), a
humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys.
Res. Commun. 333, 328–335.
8. Auerbach, R., Lewis, R., Shinners, B., Kubai, L., and Akhtar, N. (2003) Angiogenesis
assays: a critical overview. Clin. Chem. 49, 32–40.
9. Folkman, J. (997) Proceedings: tumor angiogenesis factor. Cancer Res. 34,
2109-2113.
10. Gimbrone, M. A., Jr., Leapman, S. B., Cotran, R. S., and Folkman, J. (1973) Tumor
angiogenesis: iris neovascularization at a distance from experimental intraocular
tumors. J. Natl. Cancer Inst. 50, 219–228.
11. Passaniti, A., Taylor, R. M., Pili, R., et al. (1992) A simple, quantitative method for
assessing angiogenesis and antiangiogenic agents using reconstituted basement
membrane, heparin, and fibroblast growth factor. Lab. Invest. 4, 519–528.
12. Nor, J. E., Christensen, J., Mooney, D. J., and Polverini, P. J. (1999) Vascular
endothelial growth factor (VEGF)-mediated angiogenesis is associated with
enhanced endothelial cell survival and induction of Bcl-2 expression. Am. J.
Pathol. 154, 375–384.
13. Nor, J. E., Peters, M. C., Christensen, J. B., et al. (2000) Engineering and characterization
of functional human microvessels in immunodeficient mice. Lab.
Investig. 81, 453–463.
14. Schechner, J. S., Nath, A. K., Zheng, L., et al (2000) In vivo formation of complex
microvessels lined by human endothelial cells in an immunodeficient mouse.
Proc. Natl. Acad. Sci. USA 97, 9191–9196.
15. Enis, D. R., Shepherd, B. R., Wang, Y., et al. (2005) Induction, differentiation, and
remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial
cells. Proc. Natl. Acad. Sci. USA 102, 425–430.
16. Skovseth, D. K., Yamanaka, T., Brandtzaeg, P., Butcher, E. C., and Haraldsen, G.
(2002) Vascular morphogenesis and differentiation after adoptive transfer of
human endothelial cells to immunodeficient mice. Am. J. Pathol. 160, 1629–1637.
17. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease.
Nat. Med. 1, 27–31.
18. Carmeliet, P. and Jain, R. K. (2000) Angiogenesis in cancer and other diseases.
Nature 407, 249–257.